Max Healthcare Institute shares rose over 2% to Rs 1,102.50 in Monday trade. The company reported steady financial growth and maintains a low debt-to-equity ratio of 0.27. Investors are tracking the company's expansion plans as it contin...
Read More
Torrent Pharmaceuticals shares climbed 2.07% to Rs 5,064.00 on Monday after the company reported an annual profit rise to Rs 2,138.18 crore for FY26. While annual performance showed strong growth, investors are evaluating the quarterly p...
Read More
Dr Lal PathLabs reported a 28% increase in net profit to Rs 169.5 crore for the June quarter, driven by higher realizations per test. The diagnostics company also raised its annual revenue growth guidance to the mid-teens range. Investor...
Read More
Laurus Labs shares touched a record ₹1,662.45 following a 29% jump in quarterly revenue to ₹2,026 crore. The performance was driven by growth in its CDMO and Affordable Medicines segments. The company has also raised its annual capital s...
Read More
The Primary Health Centre (PHC) in Mogla, Rajouri, has received a new portable X-ray machine and expanded its maternal healthcare services. This upgrade reduces the need for residents in remote areas to travel to distant hospitals for em...
Read More
Tata Steel has developed PIRONutri38, a nutritional iron supplement derived from steel galvanizing byproducts. The company plans to license this patented technology to food manufacturers instead of entering the consumer products market d...
Read More
Following a recent assault on medical staff in Dombivli, healthcare professionals are renewing calls for a Central Act to ensure workplace safety. Persistent violence, often linked to overcrowded facilities and administrative gaps, remai...
Read More
India has updated its Anemia Mukt Bharat Abhiyaan guidelines to match 2024 WHO standards. The shift prioritizes targeted screening and treatment over universal iron supplementation. This change could impact demand for diagnostic services...
Read More
A Comptroller and Auditor General report reveals that most COVID-era oxygen plants in West Bengal remain non-functional as of late 2023. Significant emergency health funds also remain unspent, raising concerns over public healthcare infr...
Read More
Zydus Lifesciences has moved its drug candidate, Desidustat, into Phase III clinical trials for sickle cell anaemia in partnership with the ICMR. This study aims to validate the oral therapy for a condition that has historically seen lim...
Read More
Face fitness, featuring facial yoga and non-invasive muscle stimulation, is growing rapidly in India as consumers shift away from invasive cosmetic procedures. Global players and local brands are expanding their presence in metro and tie...
Read More
Aster DM Quality Care has announced a ₹1,315 crore investment to expand its hospital network in Karnataka. The plan includes adding 1,360 new beds through three major projects in Bengaluru, aiming to strengthen its regional presence. Inv...
Read More
Aster DM Healthcare will invest ₹1,315 crore to build new hospitals and add bed capacity in Bengaluru. This move aims to increase its footprint in a key market, though investors should track the impact of this capital spending on the com...
Read More
Global investment firm Bain Capital has reached an agreement to acquire UK-based vitamin manufacturer Vitabiotics. The deal includes the company's Indian subsidiary, Meyer Organics, and aims to drive international expansion across India,...
Read More
Dr Lal PathLabs reported a 21.4% increase in net profit to ₹170 crore for the June quarter, driving a 5% jump in its stock price. The company also announced an interim dividend of ₹5 per share and revealed strategic expansion plans into...
Read More
Laurus Labs reported a 126% year-on-year rise in net profit to ₹368 crore for the quarter ended June 30, 2026. Revenue grew 29% to ₹2026 crore, supported by its contract manufacturing business and affordable medicines portfolio. The comp...
Read More
Manipal Health Enterprises plans to invest ₹4,000 crore to add 2,400 hospital beds over the next four years. The expansion aligns with the hospital chain's upcoming initial public offering, where it aims for a valuation of up to $8 billi...
Read More
India has granted regulatory approval to Takeda's Qdenga, the country's first dengue vaccine, expected to hit the market in early 2027. The two-dose vaccine targets all four common dengue strains for individuals aged 4 to 60. Given India...
Read More
Aurobindo Pharma has signed a voluntary, royalty-free licensing agreement with Merck (MSD) to manufacture and supply a generic version of the HIV prevention drug alimatravir. This deal covers 129 low- and middle-income countries, allowin...
Read More
The Telangana government has approved ₹740 crore to build 1,569 new rural health sub-centres. This initiative seeks to improve primary healthcare access and provide free diagnostic services to rural residents, potentially reducing out-of...
Read More